Pricing

BRIDGER MANAGEMENT, LLC

2 followers ยท
NEW YORK NY Investment Advisor Hedge Fund
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

Hedge fund Bridger Management is run by founder Roberto Mignone.Whalewisdom has at least 99 13F filings, 1 13D filings, and 140 13G filings Their last reported 13F filing for Q2 2024 included $194,340,423 in managed 13F securities and a top 10 holdings concentration of 72.83%. Bridger Management's largest holding is Lilly (Eli) & Co. with shares held of 24,712.
Business Description
Bridger Management, LLC ("Bridger") is an investment adviser organized as a Delaware limited liability company on April 25, 2000. Bridger is managed by Roberto Mignone (the "Manager"), and principally owned by the Manager through Bridger Management II LP. Bridger currently serves as the investment adviser, with discretionary trading authority, to private, pooled investment vehicles, the securities of which are offered through a private placement memorandum to accredited investors, as defined under the Securities Act of 1933, as amended (the "Securities Act"), and qualified purchasers, as defined under the Investment Company Act of 1940, as amended (the "1940 Act"). Bridger provides discretionary investment management services to qualified investors through its private funds: * Swiftcurrent Offshore, Ltd., a Cayman Islands exempted company (the "Swiftcurrent Offshore Fund")
Investment Strategy
The Adviser's investment strategy for the Swiftcurrent Fund is a long/short equity strategy, which involves holding both long positions in companies with identified fundamental value drivers and short positions in companies with perceived fundamental business deterioration. The Auson Fund primarily invests in private investment funds managed by third parties, while the SIV I Fund is a private pooled investment vehicle that has invested in a single biotechnology company in the healthcare sector. The Adviser's investment strategies rely on in-depth fundamental research to identify investment opportunities through field research, quantitative screens, and an extensive investment network. The Adviser seeks to acquire long positions in companies with unrecognized or underexploited fundamental value drivers, such as high growth potential, competitive advantages, or undervalued valuations. The Adviser may also seek to acquire long positions in companies with catalysts for capital appreciation, such as restructurings, spin-offs, or changes in management control.
Known Email Addresses
(Subscription Required)
Other Contact Information
(Subscription Required)

2024-06-30

Top Buys (13F)

Name % Change
BLCO Bausch + Lomb Corp 3.78%
MLCO Melco Resorts & Ente 0.96%
OSCR Oscar Health, Inc. 0.78%
HLVX HilleVax Inc 0.23%

2024-06-30

Top Sells (13F)

Name % Change
EDR Endeavor Group Holdi 5.12%
THC Tenet Healthcare Cor 4.15%
CYTK Cytokinetics Inc 2.18%
ATRC AtriCure Inc 1.37%
BBWI Bath & Body Works In 1.37%

2024-06-30

13F Holdings Summary

Name $ Change
LLY Lilly (Eli) & Co. 11.51%
UBER Uber Technologies In 11.27%
VRTX Vertex Pharmaceutica 9.9%
MS Morgan Stanley 9.39%
TEVA Teva Pharmaceutical 8.2%

2024-06-30

13F Activity

Market Value $194m, Prior: $222m
Inflows (Outflows) as % of Total MV (-16.819)%
New Purchases 2 stocks
Added To 2 stocks
Sold out of 5 stocks
Reduced holdings in 4 stocks
Top 10 Holdings % 72.83%
Turnover %[1] 21.21%
Turnover Alt %[2] 5.25%
Time Held Top 20 5.35 quarters
Time Held Top 10 4.3 quarters
Time Held All 7.18 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2024-06-30

13F Sector Allocation Over Time

limited to past 4 quarters. Subscribe to see all available data

2024-06-30

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2024-06-30

Portfolio Performance